FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained
Mar, 15 2026
Medications
Bob Bond
The FDA enforces strict bioequivalence standards for narrow therapeutic index (NTI) drugs to ensure safety. These drugs require tighter limits (90-111%) and specialized testing to prevent dangerous dosage variations. Learn which drugs are affected and what this means for patients.
